Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Improving symptoms of male urinary problems may lower the risk of death.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Medications for PCOS don't seem to raise heart disease risk.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Stem cells can improve skin grafts by enhancing blood flow and hair growth.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The SA-MS hydrogel is a promising material for improving wound healing and skin regeneration in diseases like diabetes and skin cancer.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Hair loss may increase heart disease risk.

Shorter PSADT after prostate surgery is linked to higher risk of death.

DHT may increase the risk of heart disease and death in elderly men.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Men with better urinary symptoms have a lower risk of death.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.